These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10228112)

  • 1. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype.
    Aron Y; Polla BS; Bienvenu T; Dall'ava J; Dusser D; Hubert D
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1464-8. PubMed ID: 10228112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA frequencies and associations in cystic fibrosis.
    Adriaanse MP; Vreugdenhil AC; Groeneweg M; Brüggenwirth HT; Castelijns SJ; van der Ent CK; Voorter CE; Tilanus MG
    Tissue Antigens; 2014 Jan; 83(1):27-31. PubMed ID: 24355005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7.
    Aron Y; Desmazes-Dufeu N; Matran R; Polla BS; Dusser D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1996 Jul; 26(7):821-8. PubMed ID: 8842557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
    Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
    Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
    Chauhan B; Santiago L; Hutcheson PS; Schwartz HJ; Spitznagel E; Castro M; Slavin RG; Bellone CJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):723-9. PubMed ID: 11031343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic studies in monogenic and polygenic human diseases.
    Endreffy E; László ; Szabó A; Román F; Kürti K; Kálmán M; Raskó I
    Acta Biol Hung; 1997; 48(1):121-8. PubMed ID: 9199707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis.
    Laki J; Laki I; Németh K; Ujhelyi R; Bede O; Endreffy E; Bolbás K; Gyurkovits K; Csiszér E; Sólyom E; Dobra G; Halász A; Pozsonyi E; Rajczy K; Prohászka Z; Fekete G; Füst G
    Int Immunol; 2006 Nov; 18(11):1585-90. PubMed ID: 16987934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
    El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
    Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
    Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.
    Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
    Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France.
    Claustres M; Guittard C; Bozon D; Chevalier F; Verlingue C; Ferec C; Girodon E; Cazeneuve C; Bienvenu T; Lalau G; Dumur V; Feldmann D; Bieth E; Blayau M; Clavel C; Creveaux I; Malinge MC; Monnier N; Malzac P; Mittre H; Chomel JC; Bonnefont JP; Iron A; Chery M; Georges MD
    Hum Mutat; 2000; 16(2):143-56. PubMed ID: 10923036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
    Salvatore F; Scudiero O; Castaldo G
    Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease.
    Camarena A; Juárez A; Mejía M; Estrada A; Carrillo G; Falfán R; Zuñiga J; Navarro C; Granados J; Selman M
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1528-33. PubMed ID: 11401868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.